Optiver Holding
ADCT icon

Optiver Holding’s ADC Therapeutics ADCT Stock Holding History

Optiver Holding’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.25K Buy
866
+280
+48% +$1.1K ﹤0.01% 1620
2025
Q4 		$2.07K Sell
586
-720
-55% -$2.92K ﹤0.01% 2000
2025
Q3 		$5.22K Buy
+1,306
New +$4.12K ﹤0.01% 1707

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Optiver Holding's ADCT Position: Q1 2026 in Review

Optiver Holding increased its ADC Therapeutics (ADCT) stake by 48% in Q1 2026, buying an estimated $1.1K and bringing the position to 866 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Optiver Holding first reported a position in ADCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.22K in Q3 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Optiver Holding held 866 shares of ADC Therapeutics worth $3.25K as of Q1 2026.
  • Optiver Holding bought 280 ADC Therapeutics shares in Q1 2026, an estimated $1.1K.
  • ADC Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1620 holding.
  • Optiver Holding first reported a position in ADC Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's ADC Therapeutics position peaked at $5.22K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.